Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18ß-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer.

Stecanella, Luciano A; Bitencourt, Antonio P R; Vaz, Gustavo Richter; Quarta, Eride; Silva Júnior, José O C; Rossi, Alessandra

Stecanella, Luciano A; Bitencourt, Antonio P R; Vaz, Gustavo Richter; Quarta, Eride; Silva Júnior, José O C; Rossi, Alessandra.

Afiliación

Stecanella LA; Laboratory R&D Pharmaceutical and Cosmetic, Federal University of Pará, Street Augusto Correa 01, Belém 66075-110, Brazil.
Bitencourt APR; Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy.
Vaz GR; Laboratory R&D Pharmaceutical and Cosmetic, Federal University of Pará, Street Augusto Correa 01, Belém 66075-110, Brazil.
Quarta E; Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy.
Silva Júnior JOC; Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy.
Rossi A; Laboratory of Nanotechnology Applied to Health, Postgraduate Program in Health Sciences, Federal University of Rio Grande, Av. Italia, Km 8, Rio Grande 96210-900, Brazil.

Pharmaceutics ; 13(11)2021 Oct 26.

Article en En | MEDLINE | ID: mdl-34834206

Palabras clave

drug targeting; glycyrrhetinic acid; glycyrrhizic acid; liver cancer; nanosystems

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Plantas_medicinales Idioma: En Revista: Pharmaceutics Año: 2021 Tipo del documento: Article País de afiliación: Brasil

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google